Literature DB >> 25859802

Apoplexy of pituitary adenomas: the perfect storm.

Edward H Oldfield1,2, Marsha J Merrill2.   

Abstract

OBJECT: Pituitary adenomas occasionally undergo infarction, apoplexy, which often destroys much of the tumor. It is well known that apoplexy can be precipitated by several acute factors, including cardiac surgery, other types of surgery, trauma, insulin infusion, and stimulation with administration of hypothalamic releasing factors.
METHODS: The prior focus on mechanisms underlying pituitary apoplexy has been on these acute events. Less attention has been given to the endogenous features of pituitary tumors that make them susceptible to spontaneous infarction, despite that most pituitary apoplexy occurs in the absence of a recognized precipitating event. The authors examine intrinsic features of pituitary adenomas that render them vulnerable to apoplexy-features such as high metabolic demand, paucity of angiogenesis, and sparse vascularity, qualities that have previously not been linked with apoplexy-and argue that it is these features of adenomas that underlie their susceptibility to spontaneous infarction. The sensitivity of freshly cultured pituitary adenomas to hypoglycemia is assessed.
RESULTS: Adenomas have high metabolic demand, limited angiogenesis, and reduced vessel density compared with the normal gland. Pituitary adenoma cells do not survive in the presence of reduced or absent concentrations of glucose.
CONCLUSIONS: The authors propose that the frequent ischemic infarction of pituitary adenomas is the product of intrinsic features of these tumors. These endogenous qualities create a tenuous balance between high metabolic demand and marginal tissue perfusion. Thus, the tumor is vulnerable to spontaneous infarction or to acute ischemia by any event that acutely alters the balance between tumor perfusion and tumor metabolism, events such as acute systemic hypotension, abruptly decreased supply of nutrients, hypoglycemia with insulin administration, or increase in the tumor's metabolic demand due to administration of hypothalamic releasing factors. It may be possible to take advantage of these intrinsic features of pituitary adenomas by using aspects of this vulnerability for development of new approaches for treatment.

Entities:  

Keywords:  FDG = fluorodeoxyglucose; PET = positron emission tomography; VEGF = vascular endothelial growth factor; pituitary adenoma; pituitary apoplexy; pituitary surgery

Mesh:

Substances:

Year:  2015        PMID: 25859802     DOI: 10.3171/2014.10.JNS141720

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

1.  Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant?

Authors:  Yoshikazu Ogawa; Hidefumi Jokura; Kuniyasu Niizuma; Teiji Tominaga
Journal:  J Neurooncol       Date:  2018-01-09       Impact factor: 4.130

2.  Delayed Diagnosis of Cushing's Disease in a Pediatric Patient due to Apparent Remission from Spontaneous Apoplexy.

Authors:  Sara H Rahman; Prashant Chittibonia; Martha Quezado; Nicholas Patronas; Constantine A Stratakis; Maya B Lodish
Journal:  J Clin Transl Endocrinol Case Rep       Date:  2016-12

3.  Surgical treatment of a 72-year-old patient with headache, hyponatremia and oculomotor nerve palsy: a case report and literature review.

Authors:  Hanchun Huang; Shenzhong Jiang; Chengxian Yang; Kan Deng; Renzhi Wang; Xinjie Bao
Journal:  Gland Surg       Date:  2021-01

4.  Long-Term Outcomes of Pituitary Gland Preservation in Pituitary Macroadenoma Apoplexy: Case Series and Review of the Literature.

Authors:  John Robert Souter; Ignacio Jusue-Torres; Kurt Grahnke; Ewa Borys; Chirag Patel; Anand V Germanwala
Journal:  J Neurol Surg B Skull Base       Date:  2019-11-11

5.  Predictive Clinical and Surgical Factors Associated with Recurrent Apoplexy in Pituitary Adenomas.

Authors:  Alan Siu; Sanjeet Rangarajan; Michael Karsy; Christopher J Farrell; Gurston Nyquist; Marc Rosen; James J Evans
Journal:  J Neurol Surg B Skull Base       Date:  2021-09-10

Review 6.  Apoplexy in nonfunctioning pituitary adenomas.

Authors:  Luiz Eduardo Wildemberg; Andrea Glezer; Marcello D Bronstein; Mônica R Gadelha
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

7.  Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1.

Authors:  Jie Lu; Blake K Montgomery; Grégoire P Chatain; Alejandro Bugarini; Qi Zhang; Xiang Wang; Nancy A Edwards; Abhik Ray-Chaudhury; Marsha J Merrill; Russell R Lonser; Prashant Chittiboina
Journal:  Mol Cell Endocrinol       Date:  2017-10-03       Impact factor: 4.102

8.  Comparative analysis of pituitary adenoma with and without apoplexy in pediatric and adolescent patients: a clinical series of 80 patients.

Authors:  Run Wang; Zixun Wang; Yifu Song; Longjie Li; Xiaodi Han; Sheng Han
Journal:  Neurosurg Rev       Date:  2021-04-29       Impact factor: 3.042

9.  Emergency endoscopic surgery for pituitary apoplexy presenting as cerebral infarction in a limited resources condition: A case report.

Authors:  He Van Dong; Dat Tran; Hung Thanh Chu; Anh Hoang Pham; Xuan Thanh Nguyen; Ha Dai Duong
Journal:  Int J Surg Case Rep       Date:  2021-05-26

Review 10.  Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature.

Authors:  Rafael Martinez-Perez; Michael W Kortz; Benjamin W Carroll; Daniel Duran; James S Neill; Gustavo D Luzardo; Marcus A Zachariah
Journal:  World Neurosurg       Date:  2021-06-12       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.